Deal Library / Pharma BD Deal Intelligence
Nephrology Deals
The Pharma Closeout tracks 17 deals, $27.7B in disclosed deal value, 13 with a post-close Outcome Score for Nephrology.
Median Critic Score: 80 · Median Outcome Score: 59
Best outcome: Horizon Pharma plc / Crealta Holdings LLC (87) · Weakest outcome: Endo Pharmaceuticals Holdings Inc. / HealthTronics, Inc. (17)
All 17 deals
- Horizon Pharma plc / Crealta Holdings LLC — 2015 · $510M · Worked — the deal delivered on its rationale.
- Novartis AG / Chinook Therapeutics Inc. — 2023 · $3.5B · Worked — the deal delivered on its rationale.
- Ipsen S.A. / Memo Therapeutics AG — 2026 · $797M · Largely worked — most objectives met.
- Eli Lilly and Company / Ascidian Therapeutics, Inc. — 2026 · $1.9B · Largely worked — most objectives met.
- Novartis AG / Regulus Therapeutics — 2025 · $1.7B · Largely worked — most objectives met.
- Genzyme Corporation / Bone Care International, Inc. — 2005 · $600M · Largely worked — most objectives met.
- AstraZeneca PLC / CSPC Pharmaceutical Group Ltd. — 2026 · $1.8B · Mixed — partial payoff, real shortfalls.
- Merck & Co. Inc. / Eisai Co., Ltd. — 2017 · $5.8B · Mixed — partial payoff, real shortfalls.
- Takeda Pharmaceutical Company Ltd. / URL Pharma, Inc. — 2012 · $800M · Mixed — partial payoff, real shortfalls.
- Gilead Sciences Inc. / Goldfinch Bio Inc. — 2019 · $240M · Did not work — the deal failed to deliver.
- AstraZeneca PLC / Ardea Biosciences, Inc. — 2012 · $1.3B · Did not work — the deal failed to deliver.
- Shire plc / Pervasis Therapeutics, Inc. — 2012 · $200M · Did not work — the deal failed to deliver.
- Endo Pharmaceuticals Holdings Inc. / HealthTronics, Inc. — 2010 · $223M · Did not work — the deal failed to deliver.
- Biogen Inc. / Apellis Pharmaceuticals, Inc. — 2026 · $5.6B
- SERB Pharmaceuticals SA / Hansa Biopharma AB — 2026 · $134M
- Swedish Orphan Biovitrum AB (Sobi) / Arthrosi Therapeutics, Inc. — 2025 · $1.5B
- Alexion Pharmaceuticals, Inc. / Achillion Pharmaceuticals, Inc. — 2019 · $1.2B
← Deal Library ·
Interactive search ·
How we score deals